Login / Signup

Inhibitors of Transforming Growth Factor Beta Receptor 1 (TGFβr1) May Enhance the Efficacy of Several Monoclonal Antibodies as Cancer Therapy.

Ahmed F Abdel-Magid
Published in: ACS medicinal chemistry letters (2022)
Keyphrases
  • transforming growth factor
  • cancer therapy
  • epithelial mesenchymal transition
  • drug delivery
  • signaling pathway
  • binding protein